PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 25, 2014Obesity Reviews110 citations

Duodenal switch versus Roux‐en‐Y gastric bypass for morbid obesity: systematic review and meta‐analysis of weight results, diabetes resolution and early complications in single‐centre comparisons

View Full Paper
JHJakob HedbergJSJohan SundströmMSMagnus Sundbom

Key Result

Biliopancreatic diversion with duodenal switch yielded 6.2 additional body mass index units of weight loss compared with Roux-en-Y gastric bypass (95% CI 5.0-7.5; P<0.001).

Study Design

Type

Meta-Analysis (n=2,023)

Multicenter

No

Structured PICO

Does biliopancreatic diversion with duodenal switch improve weight loss compared to Roux-en-Y gastric bypass in morbidly obese patients?

P
Population
2,023 morbidly obese patients (874 DS and 1,149 RYGB operations) from 16 single-centre comparison studies
I
Intervention
Biliopancreatic diversion with duodenal switch (DS)
C
Comparator
Roux-en-Y gastric bypass (RYGB)
O
Outcome
Difference in weight losssurrogate

Duodenal switch provides greater weight loss than Roux-en-Y gastric bypass in morbidly obese patients, but is associated with higher rates of early complications and potentially higher perioperative mortality.

Main Result

Effect estimate: Mean difference 6.2 BMI units (95% CI 5.0-7.5)

p-value: p=<0.001

Abstract

Long-term weight loss after Roux-en-Y gastric bypass (RYGB) in super-obese patients has not been ideal. Biliopancreatic diversion with duodenal switch (DS) is argued to be better; however, additional side effects are feared. The aim of the present study was to determine differences in results after DS and RYGB in publications from single-centre comparisons. A systematic review of studies containing DS and RYGB performed at the same centre was performed. Outcome data were weight results, resolution of comorbid conditions, perioperative results and complications. Main outcome was difference in weight loss after DS and RYGB. Secondary outcomes were difference in resolution of comorbidities, perioperative results and complications. The final analysis included 16 studies with in total 874 DS and 1,149 RYGB operations. When comparing weight results at the longest follow-up of each study, DS yielded 6.2 (95% confidence interval 5.0-7.5) body mass index units additional weight loss compared with RYGB, P < 0.001. Operative time and length of stay were significantly longer after DS, as well as the risk for post-operative leaks, P < 0.05. DS is more effective than RYGB as a weight-reducing procedure. However, this comes at the price of more early complications and might also yield slightly higher perioperative mortality.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hedberg et al. (2014) conducted a meta-analysis in Morbid obesity (n=2,023). Biliopancreatic diversion with duodenal switch (DS) vs. Roux-en-Y gastric bypass (RYGB) was evaluated on Difference in weight loss (Mean difference 6.2 BMI units, 95% CI 5.0-7.5, p=<0.001). Biliopancreatic diversion with duodenal switch yielded 6.2 additional body mass index units of weight loss compared with Roux-en-Y gastric bypass (95% CI 5.0-7.5; P<0.001).

synapsesocial.com/papers/6a08628c113ba5b476de1ffdhttps://doi.org/10.1111/obr.12169
Ask AI
Helpful
Bookmark
Share
View Full Paper